CTRI Number |
CTRI/2021/12/038806 [Registered on: 21/12/2021] Trial Registered Prospectively |
Last Modified On: |
31/08/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Single Arm Study |
Public Title of Study
|
To Evaluate Safety and Efficacy of Pathadi Ghanavati and Pathadi Oil in Psoriasis |
Scientific Title of Study
|
A Single Arm Clinical Trial of Pathadi Ghanavati and Pathadi Oil in Psoriasis |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Rupali Ramadas Patil |
Designation |
Assistant Professor Department of Kayachikitsa |
Affiliation |
Hon Shri Annasaheb Dange Ayurved Medical College Ashta, Sangli |
Address |
Department of Kayachikitsa
Hon Shri Annasaheb Dange Ayurved Medical College and Postgraduate Research center, Ashta,Sangli
Sangli MAHARASHTRA 416301 India |
Phone |
9225633321 |
Fax |
|
Email |
rpcoolrupali@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr D G Dipankar |
Designation |
Professor Department of Kayachikitsa |
Affiliation |
Dr D Y Patil College of Ayurved and Research Center, pimpari, Pune |
Address |
Department of Kayachikitsa
Dr D.Y.Patil College of Ayurved and Research center,Pimapari,Pune-18
Pune MAHARASHTRA 411018 India |
Phone |
9822279321 |
Fax |
|
Email |
drdgdipankar@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Rupali Ramadas Patil |
Designation |
Assistant Professor Department of Kayachikitsa |
Affiliation |
Hon Shri Annasaheb Dange Ayurved Medical College Ashta, Sangli |
Address |
Department of Kayachikitsa
Hon Shri Annasaheb Dange Ayurved Medical College and Postgraduate Research center, Ashta,Sangli
Sangli MAHARASHTRA 416301 India |
Phone |
9225633321 |
Fax |
|
Email |
rpcoolrupali@gmail.com |
|
Source of Monetary or Material Support
|
Dr D. Y. Patil College of Ayurved and Research center, Pimpari, Pune-18 |
Hon. Shri. Annasaheb Dange Ayurved Medical College & Post Graduate Research Center, Ashta, Tal Walwa Dist Sangli,416301 Sangli |
|
Primary Sponsor
|
Name |
HON SHRI ANNASAHEB DANGE AYURVED MEDICAL COLLEGE AND POSTGRADUATE CENTER ASHTA SANGLI |
Address |
Department Kayachikitsa Hon. Shri. Annasaheb Dange Ayurved Medical College & Post Graduate Research Center, Ashta, Tal Walwa Dist Sangli,416301 Sangli Maharashtra |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
Name |
Address |
DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTER PIMPARI PUNE |
Department Kayachikitsa Dr D Y Patil College of Ayurved and Research center, Pimpari, Pune-18 |
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 2 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Rupali Ranmadas Patil |
Hon Shri Annasaheb Dange Ayurved Medical College and Postgraduate Research Center,Ashta,Sangli |
Department Kayachikitsa OPD/IPD Sangli MAHARASHTRA |
9225633321
rpcoolrupali@gmail.com |
Dr Rupali Ramadas Patil |
Dr D Y Patil College of Ayurved and Research Center, Pimpari, Pune |
Department Kayachikitsa OPD/IPD Pune MAHARASHTRA |
9225633321
rpcoolrupali@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 3 |
Name of Committee |
Approval Status |
Institutional Ethical Committee |
Approved |
Institutional Ethics Committee |
Approved |
Research and Recognition Committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:L409||Psoriasis, unspecified. Ayurveda Condition: KITIBAH, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Pathadi Ghanavati, Reference: Ashtang Hriday Kushta Chikitsa, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Koshna Jala), Additional Information: | 2 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Pathadi Oil, Reference: Ashtang Hriday Kushta Chikitsa, Route: Topical, Dosage Form: Taila, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Muhurmuhu, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: To be applied on the affected area |
|
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
1.Patients who are having sign and symptoms of Psoriasis
2.Patients suffering from psoriasis with less than 50% of the body surface involvement
|
|
ExclusionCriteria |
Details |
1.Pregnant and lactating mothers
2.Patients having any severe systemic disorders like Diabetes Mellitus, Cancer etc.
3.Patients suffering from psoriasis with more than 50% of the body surface involvement and with other co morbidities
|
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
1. Improvement in Dermatology Life Quality Index(DLQI)
2. Improvement in Signs and Symptoms of Psoriasis |
7th Day, 14th Day,21th Day,30th Day |
|
Secondary Outcome
|
Outcome |
TimePoints |
1. Reduction in mean Simplified Psoriasis Area and Severity Index Score (SPASI)
2. Reduction in mean Physicians Global Assessment Scale Score (PGA)
3. Reduction in mean Physicians Global Assessment and Body Surface Area Scale Score |
7th Dya, 14th Day, 21th Day,30th Day |
|
Target Sample Size
|
Total Sample Size="50" Sample Size from India="50"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
01/01/2022 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
|
Nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Psoriasis is common dermatological disease affecting up to 0.09 to 11.4 % of world’s population and approximately 3% of Indian population. It is a chronic inflammatory, non communicable, disfiguring and disabling disease. It involves the skin, nails and is associated with a number of co morbidities. Psoriasis originates from the Greek word “Psora†that means “itchâ€. It occurs mostly in second and fourth decade of life and affects male and female equally. The skin is largest organ of the body and is considered as “Organ of expressionâ€. Due to disfiguring, psoriasis has a negative effect on the daily life, self confidence and self esteem. The prevalence of the psoriasis in India is increasing day by day. Increasing prevalence and its association with various co morbidities affects quality of life of patients suffering from psoriasis. So there is a need for research on various aspects such as epidemiology, etio- pathogenesis, and management. There is a large gap addressing the therapeutic aspects of the psoriasis where there is no definitive curative therapy available. Ayurveda Medicines has shown considerable effects in the Psoriasis. Thus, the present study is undertaken to evaluate efficacy of Pathadi Ghanavati and Pathadi Oil in the management of Kitibha (Psoriasis). 50 patients who are having signs and symptoms of Psoriasis as mentioned in inclusion criteria will be selected and treated with Pathadi Ghanavati internally and Pathadi Oil external application for 30 days. Assessment will be done on the basis of percentage relief in signs and symptoms of the Psoriasis. The reduction in mean score of Simplified Psoriasis Area and Severity Index, Physician’s Global Assessment Scale, Physician’s Global Assessment Scale and Body Surface Area Scale and Improvement in Dermatology Life Quality Index. Appropriate statistical tests will be applied to test the significance. Diet will be advised according to physical constitution or Prakriti to prevent recurrence of the disease. |